What is the global market size of In-Vitro Colorectal Cancer Screening Tests Market?

In-Vitro Colorectal Cancer Screening Tests Market size was valued at USD 22.68 billion in 2021 and is poised to grow from USD 23.79 billion in 2022 to USD 64.7 billion by 2030, growing at a CAGR of 11.1% in the forecast period (2023-2030).

Global In-Vitro Colorectal Cancer Screening Tests Market

In-Vitro Colorectal Cancer Screening Tests Market Size, Share, Growth Analysis, By Product Type(Fecal Occult Blood Tests, Biomarker Tests, CRC DNA Screening Tests, Guaiac FOB Stool Test), By End User(Hospitals, Clinics, Diagnostics laboratories, Ambulatory Surgical Centers), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35E2011 | Region: Global | Published Date: July, 2036
Pages: 200 | Tables: 72 | Figures: 75

In-Vitro Colorectal Cancer Screening Tests Market News

In July 2022, in Singapore, a research has been started for the identification and validation of novel biomarker combinations that can identify many cancers early. This week, the biotechnology business MiRXES Ptr Ltd revealed that Project CADENCE had begun after a memorandum of agreement was signed (Cancer Detected Early caN be CurEd).
In July 2022, with assistance from Amazon Web Services' (AWS) Health Equity Initiative, Medtronic plc (NYSE:MDT), a leader in healthcare technology, and the American Society for Gastrointestinal Endoscopy (ASGE) announced they are expanding the Medtronic Health Equity Assistance Program for colon cancer screening in medically underserved communities across the United States. From 50 to 133 GI Genius units, spread throughout 62 locations, have been provided as part of the initiative.

In-Vitro Colorectal Cancer Screening Tests Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

In-Vitro Colorectal Cancer Screening Tests Market size was valued at USD 22.68 billion in 2019 and is poised to grow from USD 23.79 billion in 2023 to USD 64.7 billion by 2031, growing at a CAGR of 11.1% in the forecast period (2024-2031).

The existence of several international players defines the global market. To increase their market share, businesses use a variety of techniques, including partnerships, agreements, regional growth, mergers, acquisitions, and new product creation. In our in-vitro colorectal cancer screening tests market reports, some of the leading quality in-vitro colorectal cancer screening tests manufacturers are as follows: Abbott (US), F. Hoffmann-La Roche AG (Switzerland), Quest Diagnostics (US), Sysmex Corporation (Japan), Siemens Healthcare (Germany), Alere Inc. (US), Eiken Chemical (Japan), Siemens AG (Germany), OncoCyte Corporation-Biotime (US), Merck KGaA (Germany). 'Abbott Laboratories', 'Beckman Coulter, Inc.', 'Bio-Rad Laboratories, Inc.', 'Exact Sciences Corporation', 'F. Hoffmann-La Roche AG', 'Genomic Health, Inc.', 'Hologic, Inc.', 'Illumina, Inc.', 'Invitae Corporation', 'Laboratory Corporation of America Holdings', 'Myriad Genetics, Inc.', 'Natera, Inc.', 'NeoGenomics Laboratories, Inc.', 'QIAGEN N.V.', 'Quest Diagnostics Incorporated', 'Siemens Healthineers AG', 'Sysmex Corporation', 'Thermo Fisher Scientific Inc.', 'VolitionRX Limited', 'Zymo Research Corporation'

The prevalence of colorectal cancer (CRC) is increasing as a result of numerous causes, including the ageing population, the adoption of an unhealthy lifestyle, and diabetes.

One of the main factors propelling the market's expansion is the rising frequency of colorectal cancer among the general population. Additionally, growing public awareness of the advantages of early cancer detection and prompt treatment is favourably affecting market expansion. The market is expanding as a result of numerous technological developments, such as the inclusion of genetic testing in cancer screening tests. These tests support early detection, the creation of treatment regimens, stopping the spread of cancerous cells, and lowering the dangers of afflicted conditions.

The North American, European, Asian-Pacific, Latin American, and Middle Eastern regions of the market for in-vitro colorectal cancer screening tests were used to split the market for regional analysis. In-vitro testing for colorectal cancer were the market leader in 2021 in North America.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

In-Vitro Colorectal Cancer Screening Tests Market News

In-Vitro Colorectal Cancer Screening Tests Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of In-Vitro Colorectal Cancer Screening Tests Market?

Who are the key vendors in the In-Vitro Colorectal Cancer Screening Tests Market?

What is the key driver of In-Vitro Colorectal Cancer Screening Tests Market?

What is the key market trend for In-Vitro Colorectal Cancer Screening Tests Market?

Which region accounted for the largest share in In-Vitro Colorectal Cancer Screening Tests Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300